New nano drug candidate kills aggressive breast cancer cells, U of A researchers say
FAYETTEVILLE, Ark.- Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
According to a news release from the University of Arkansas, triple negative breast cancer is one of the most aggressive and fatal types of breast cancer. Researchers say it will help clinicians target breast cancer cells directly, while avoiding the adverse, toxic side effects of chemotherapy.
The study was published in the June issue of Advanced Therapeutics.
Researchers led by Hassan Beyzavi, assistant professor in the Department of Chemistry and Biochemistry, linked a new class of nanomaterials, called metal-organic frameworks, with the ligands of an already-developed photodynamic therapy drug to create a nano-porous material that targets and kills tumor cells without creating toxicity for normal cells.
Snip
https://www.kark.com/news/health-news/new-nano-drug-candidate-kills-aggressive-breast-cancer-cells-u-of-a-researchers-say/
